HealthcareServices

Actinic Keratosis Market Forecast: How Big Will It Be by 2030?

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the actinic keratosis market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Actinic Keratosis Market expected to reach by 2030?

The actinic keratosis market has experienced robust expansion over the past few years. Projections indicate a rise from $8.42 billion in 2025 to $8.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this historical growth include rising uv exposure and sunburn incidence, limited availability of effective topical agents, increasing skin cancer prevalence, growing dermatology infrastructure, and the adoption of conventional surgical procedures.

The actinic keratosis market is poised for significant expansion in the coming years, with expectations to reach $11.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.6%. This anticipated growth throughout the forecast period stems from the advancement of innovative photodynamic therapies, the increasing utilization of combined topical and procedural treatments, the broadening reach of hospital and dermatology clinic networks, heightened consumer awareness regarding early intervention, and the introduction of novel homecare treatment solutions. Prominent trends for the forecast period encompass an elevated focus on sun protection and skin health, a rising preference for non-invasive photodynamic therapy, increased usage of topical therapeutics for early-stage actinic keratosis, the expansion of dermatology clinics and homecare treatment options, and a growing inclination towards combination therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

What Drivers Are Driving Adoption Within The Actinic Keratosis Market?

A rise in severe sunburn incidents is anticipated to boost the expansion of the actinic keratosis market in the future. These intense skin burns, caused by overexposure to ultraviolet (UV) radiation, manifest as redness, pain, swelling, and occasionally blisters. Contributing factors to sunburns include extended exposure to ultraviolet (UV) radiation, insufficient sun protection, more outdoor pursuits during intense UV periods, and escalating temperatures resulting from climate change. Sunburns contribute to actinic keratosis by inflicting DNA damage in skin cells via ultraviolet (UV) radiation, which generates mutations that impair typical cell function, thereby fostering the formation of precancerous lesions, particularly after repeated or extended sun exposure. For example, data from May 2024, shared by Melanoma Focus, a UK charity, indicated 201 hospitalizations for sunburn in 2022-23, which included 89 children and 25 infants under one year of age. Furthermore, the charity discovered that 66% of adults in the UK aged 16-65 recalled having sunburns during childhood, with 65% of these individuals enduring severe blistering sunburn at least once. This percentage escalated to 77% for individuals possessing light, pale, or white skin tones. Consequently, the rising occurrence of severe sunburns is propelling the expansion of the actinic keratosis market.

What Segments Are Included Within The Actinic Keratosis Market?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies

3) By End-User: Hospitals, Dermatology Clinics, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Combination Therapies

How Are Emerging Trends Affecting The Progression Of The Actinic Keratosis Market?

Leading companies in the actinic keratosis market are concentrating on developing topical ointments to effectively target and eliminate precancerous lesions, reduce recurrence rates, and improve patient compliance through shorter treatment durations and enhanced safety profiles. These topical ointments are medicated creams or gels applied directly to the affected skin, containing active ingredients such as tirbanibulin, which operate by targeting abnormal keratinocytes to address precancerous lesions. For instance, in June 2024, Almirall SA, a biopharmaceutical company based in Spain, secured approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) to broaden the application area for its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment functions as a microtubule inhibitor, specifically designed to prevent the proliferation of abnormal keratinocytes, thereby effectively reducing the number and size of precancerous lesions for the management of actinic keratosis (AK) on the face or scalp.

Who Are The Prominent Global Companies Shaping The Actinic Keratosis Market Landscape?

Major companies operating in the actinic keratosis market are Galderma SA, LEO Pharma A/S, Almirall S.A., Bausch Health Companies Inc., Perrigo Company plc, Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GSK plc, Amgen Inc., Incyte Corporation, Aclaris Therapeutics Inc., Biofrontera AG, Hill Dermaceuticals Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Viatris Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Actinic Keratosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2026, By The Business Research Company

Keloids Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Neurotrophic Keratitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Scleroderma Market Report 2026

https://www.thebusinessresearchcompany.com/report/scleroderma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795